News in the Life Sciences Industry

UPPSALA, Sweden, Nov. 14, 2019 /PRNewswire/ -- Sweden's first-ever patient to be treated on the groundbreaking Elekta Unity MR-Linac radiation therapy system took place at Uppsala University Hospital yesterday. Elekta Unity gives doctors the "vision" to zero in on tumors and avoid healthy tissues... Read more ››

STOCKHOLM, Nov. 13, 2019 /PRNewswire/ -- Thomas Eklund, member of the board, has announced that he resigns effective today from the Board of SciBase Holding AB at his own request.

LINKÖPING, Sweden, Nov. 13, 2019 /PRNewswire/ -- AMRA Medical's research is regarded as highly valuable by AASLD; the abstract... Read more ››

STOCKHOLM, Nov. 13, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company's Board has resolved to find a new CEO to lead the company into its next phase. Kjell G. Stenberg has decided to step down from his position as CEO of the company... Read more ››

STOCKHOLM, Nov. 13, 2019 /PRNewswire/ -- January 1 - September 30, 2019

LINKÖPING, Sweden and ALMERE, the Netherlands, Nov. 13, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

The brand's new wellness and lifestyle concepts will be piloted at the avant-garde SO/ Vienna in advance of a wider global roll-out

STOCKHOLM, Nov. 12, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (STO: SOBI) and Dova Pharmaceuticals, Inc. (Dova) (NASDAQ: DOVA) announced today the completion of the acquisition of Dova by Sobi.

STOCKHOLM, Nov. 11, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the hiring of Dr. Coenraad Tamse as Vice President, International Sales. Dr. Tamse brings more than 20 years of commercial,... Read more ››

BRUSSELS, Nov. 8, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced important new rheumatology data being presented on CIMZIA® (certolizumab pegol) and investigational molecules bimekizumab and dapirolizumab pegol at the 2019 American College of Rheumatology and the... Read more ››

UPPSALA, Sweden , Nov. 8, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the company will present at the Jefferies Healthcare Conference on Wednesday, November 20, 2019, at 10.40 am... Read more ››

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery.